National Institute of Oncology Rabat-Morocco

National Institute of Oncology I.N.O. Rabat, Morocco : New Cases

Female Genital Organs I.N.O : 18.9 % Number of Patients % CERVIX % CORPUS8807.9% OVARY % OTHERS6245.6%

Male Genital Organs I.N.O : 1.20 % Number of Patients % PROSTATE % TESTIS % PENIS191.70%

Lip, Oral, Cavity and Pharynx I. N.O : 9.40% Number of Patients% LIP4438% TONGUE % SALIVARY GDE2684.8% GINGIVA641.1% FLOOR MOUTH230.4 OTHER MOUTH OROPHARYNX2965.3% NASOPHARYNX330660% HYPOPHARYNX2324.2% PHARYNX3165.6%

Digestive Organs I.N.O : 10.6 % Number of Patients% ESOPHAGUS % STOMACH % INTESTINE1232% COLON5899.5% RECTUM % LIVER IHBD2644.2% GALLBADDER EBT % PANCREAS3044.9% OTHER D. O2033.3%

Nasal Cavity, Bronchus, and Lung I.N.O : 9% Number of Patients % ACCESSORY SINUSES % LARYNX % LUNG % PLEURA320.6% THYMUS811.5%

Breast I.N.O : 16 %

Bone, Soft Tissues, and Skin I.N.O Number of Patients % BONE % SOFT TISSUES % SKIN %

Central Nervous System and Thyroid GD I.N.O Number of Patients % CENTRAL NERVOUS SYSTEM 11872% THYROID GD %

Urinary Tract I.N.O :2.3% Number of Patients % BLADDER % KIDNEY %

Leukemia - Lymph Nodes INO Number of Patients % LEUKEMIA % LYMPH NODES %

Unknown Primary Site I.N.O %

SUMMARY I BREST16 % FEMALE GENITAL ORGANS ( CERVIX 75.20% ) 18.9 % 35 % DEGESTIVE ORGANS ( RECTUM 30 % ) 12.5 % L I P. ORAL CAVITY PHARYNX ( NASOPHARYNX 60 % ) 9.40 % RESPIRATORY SYSTEM ( LUNG 60.2 % ) 9 %

SUMMARY II SKIN7.4 % LYMPH NODES5.7 % URINARY TRACT2.3 % MALE GENITAL ORGANS 1.2 % UNKNOWN PRIMARY SITE 4.3 % OTHER15.2 %